These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 34540789)
21. Exploration of health professional stakeholders' views and experiences regarding minor ailments services' education, training and assessment. Aly M; Schneider CR; Sukkar MB; Lucas C Int J Clin Pharm; 2021 Jun; 43(3):654-665. PubMed ID: 33125624 [TBL] [Abstract][Full Text] [Related]
22. A mixed methods analysis of community pharmacists' perspectives on delivering COPD screening service to guide future implementation. Fathima M; Saini B; Foster JM; Armour CL Res Social Adm Pharm; 2019 Jun; 15(6):662-672. PubMed ID: 30131254 [TBL] [Abstract][Full Text] [Related]
23. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views. Butt F; Ream E Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523 [TBL] [Abstract][Full Text] [Related]
24. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan. Almansour HA; Chaar B; Saini B Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428 [TBL] [Abstract][Full Text] [Related]
25. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Wells KM; Thornley T; Boyd MJ; Boardman HF Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701 [TBL] [Abstract][Full Text] [Related]
26. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study. Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO BMC Fam Pract; 2018 May; 19(1):54. PubMed ID: 29743018 [TBL] [Abstract][Full Text] [Related]
27. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies. Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051 [TBL] [Abstract][Full Text] [Related]
28. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges. Hattingh HL; Kelly F; Fowler J; Wheeler AJ Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302 [TBL] [Abstract][Full Text] [Related]
29. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists. Sato N; Fujita K; Kushida K; Chen TF Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461 [TBL] [Abstract][Full Text] [Related]
30. Pharmacists views on participating in New Zealand's community pharmacy anticoagulation management service: a mixed-methods study. Beyene K; Chan AHY; Barton E; Yan S; Singh S; Basani A; Voong J; Harrison J Int J Clin Pharm; 2021 Feb; 43(1):251-262. PubMed ID: 32920685 [TBL] [Abstract][Full Text] [Related]
31. Community needs and preferences for community pharmacy immunization services. Al Aloola N; Alsaif R; Alhabib H; Alhossan A Vaccine; 2020 Jul; 38(32):5009-5014. PubMed ID: 32540273 [TBL] [Abstract][Full Text] [Related]
32. Pharmacists' experiences and views on providing screening services: An international comparison. Alzubaidi H; Namara KM; Saidawi W; Hasan S; Krass I Res Social Adm Pharm; 2020 Nov; 16(11):1558-1568. PubMed ID: 32830071 [TBL] [Abstract][Full Text] [Related]
33. Hospital pharmacists' ethical exposure and decision-making. So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299 [TBL] [Abstract][Full Text] [Related]
34. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study. Ting KN; Stratton-Powell DM; Anderson C Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371 [TBL] [Abstract][Full Text] [Related]
35. Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions. Hake KL; Carroll JC; Somma McGivney MA; Coley KC J Am Pharm Assoc (2003); 2021; 61(4S):S85-S90. PubMed ID: 33781696 [TBL] [Abstract][Full Text] [Related]
36. "Basically you wait for an 'in''': community pharmacist views on their role in weight management in New Zealand. Gray L; Chamberlain R; Morris C J Prim Health Care; 2016 Dec; 8(4):365-371. PubMed ID: 29530162 [TBL] [Abstract][Full Text] [Related]
37. Exploring community pharmacists' use of health literacy interventions in their everyday practice. Cork T; White S Res Social Adm Pharm; 2022 Nov; 18(11):3948-3952. PubMed ID: 35810054 [TBL] [Abstract][Full Text] [Related]
38. A pharmacist-delivered smoking cessation program in Qatar: an exploration of pharmacists' and patients' perspectives of the program. El Hajj MS; Sheikh Ali SAS; Awaisu A; Saleh R; Kheir N; Shami R Int J Clin Pharm; 2021 Dec; 43(6):1574-1583. PubMed ID: 34080087 [TBL] [Abstract][Full Text] [Related]
39. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design. Buss VH; Shield A; Kosari S; Peterson GM; Naunton M Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556 [TBL] [Abstract][Full Text] [Related]
40. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services. Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]